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Pulmonary carcinoid tends to show intraluminal growth. However, pulmonary atypical carcinoid
showing bronchial tree-like cast is extremely rare. A 63-year-old man was admitted to our hospital
because of cough and sputum. Imaging modalities including XP, US, CT, and MRI showed bronchial tree-
like tumor shadow in the right middle and lower lobes. Transbronchial biopsy revealed atypical carci-
noid. A lobectomy of the right middle and lower lobe and lymph node dissection were performed.
Grossly, the resected specimens showed cast-like tumor within the bronchial tree. It contained necrotic
areas. Microscopically, the tumor cells were arranged in trabecular, ribbon, and insular patterns. There
were many necrotic areas. The tumor cells showed hyperchromatic nuclei, and mitotic ﬁgures were
recognized in 4 per 2 mm2. Parenchymal invasion was not recognized. Lymphovascular permeation was
absent. Immunohistochemically, the tumor cells were positive for cytokeratins, synaptophysin, chro-
mogranin, CD56, and neuron-speciﬁc enolase, but negative for S100 protein, melanosome, p53 protein,
and KIT. The Ki-67 labeling was 15%. The tumor cells were stained with Grimelius stains. The lymph
nodes showed no metastatic lesions. Therefore, atypical carcinoid was diagnosed. The patient was fol-
lowed up with adjuvant chemotherapy, and is now alive free from tumor 7 years after the operation. In
summary, clinicians and pathologists should be aware that atypical carcinoid can show branchial tree-
like casts within the bronchial lumens but without parenchyma invasion. Such atypical carcinoids may
have favorable prognosis.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Pulmonary carcinoid is an uncommon tumor in the lung.
According to WHO blue book,1 carcinoid tumors are characterized
by growth patterns (organoid, trabecular, insular, palisading,
ribbon, rosette-like arrangements) that suggest neuroendocrine
differentiation. Tumor cells have uniform cytoplasmic features with
moderate eosinophilic, ﬁnely granular cytoplasm, and nuclei with
a ﬁnely granular chromatin pattern.1 Carcinoid tumor is classiﬁed
into typical and atypical ones, depending on themitotic activity and
the presence of necrosis.1 Typical carcinoid is deﬁned as a carcinoid
tumor with fewer than 2 mitoses per 2 mm2and lacking necrosis.1
In contrast, atypical carcinoid is deﬁned as a carcinoid tumor with
2–10 mitoses per 2 mm2 and/or foci of necrosis.1 The 2 mm2
corresponds to 10 high power ﬁelds of the light microscopy.1
Carcinoid tumors tend to show intraluminal growth.1–4
However, carcinoid entirely composed of intrabranchial elements
with features of bronchial tree cast is extremely rare. Here, therved.author presents a surgical case of atypical carcinoid with this
intrabranchial tree cast-like features without invasion.2. Case report
A 63-year-old man presented with longstanding cough and
sputum and was admitted to our hospital for scrutiny. A blood
laboratory test showed mild anemia and tumor markers were
within normal ranges. However, imaging modalities including
chest-XP, US, CT, and MRI revealed a bronchial tree-like tumor
shadow in the right middle and lower lobes. A transbronchial
biopsy was obtained, and it was diagnosed as an atypical carcinoid
by the author. Therefore, a lobectomy of the right middle and lower
lobe and lymph node dissection were performed. Gross ﬁndings
were very impressive. Grossly, the resected specimens showed
cast-like tumor in most of the bronchial tree (Fig. 1A and B). It
contained necrotic areas. No invasive features were recognized.
Thirty-eight sections were examined for histology. Microscopically,
the tumor cells were consisted of monotonous cells with relatively
monotonous hyperchromatic nuclei and monotonous acidophilic
cytoplasm (Fig. 2), Tumor cells were arranged in trabecular, ribbon-
Fig. 1. A and B: cut surface of the lung. A bronchial tree-like tumor is seen, as if it is a bronchial tree cast. The tumor is totally within the branchial lumens.
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(Fig. 3). Mitotic ﬁgures were recognized in 4 per 2mm2 (10 high
power ﬁelds). No lymphovascular permeation was recognized.
Parenchymal invasions were absent, but the tumor was pushing the
parenchyma (Fig. 4). The bronchial surgical margin was negative.
The pleura was not involved by tumor cells. Therefore, the author
thought that the tumor was completely removed and the prognosisFig. 2. Microscopic ﬁndings. The tumor cells show neuroendocrine features such as
ribbon, trabecular, and insular patterns. The tumor cells are relatively monotonous. HE,
200.will be relatively good. The mucus impactions were recognized in
the periphery of the intrabronchial atypical carcinoma, but they
were scant in amount. The lung parenchyma showed obstructive
bronchopneumonia.
An immunohistochemical analysis was performed with the use
of Dako Envision method (Dako, Glostrup, Denmark), as described
previously.5,6 No melanin pigment was recognized by HE and
Masson-Fontana stains Tumor cells were positively labeled with
Grimelius stain. Immunohistochemically, the tumor cells wereFig. 3. There is a necrotic foci with the atypical carcinoid, 200.
Fig. 4. The carcinoid tumor within the peripheral bronchus. The tumor is located
within the bronchi, pissing lung parenchyma. No invasion is seen. HE, 200.
Fig. 6. The tumor cells are positive for chromogranin, 200.
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wide, Dako, Beckton-Dickinson, CA, USA), chromogranin (Fig. 6)
(DAK-A3, Dako), synaptophysin (polyclonal, Dako), neuron-speciﬁc
enolase (BBS/NC/VI-H14, Dako), CD56 (MOC-1, Dako), and PDGFRA
(Santa Cruz, CA, USA). In contrast, the tumor cells were negative for
S100 protein, vimentin (Vim 3B4, Dako), melanosome (HMB45,
Dako), p53 protein (DO-7, Dako), CD34 (QBEND10, Dako), desmin
(D33, Dako), a-smooth muscle actin (1A4), KIT (polyclonal, Dako),
CD3 (M7193, Dako), CD79a (M7050, Dako), and CD20 (L26, Dako).
Ki-67 labeling (MIB1, Dako) was 15%. The lymph nodes (n¼ 15)
showed no metastatic lesions. Therefore, atypical carcinoid was
diagnosed. The patient was followed up with adjuvant chemo-
therapy, and is now alive free from tumor 7 years after the
operation.
3. Discussion
Pulmonary neuroendocrine tumors were classiﬁed into typical
carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma
(LCNEC), and small cell lung carcinoma (SCLC).7 These tumors were
characterized by neuroendocrine features, which indicate positive
neuroendocrine antigens including CD56, chromogranin, synapto-
physin and neuron-speciﬁc enolase as well as positiveFig. 5. The tumor cells are positive for cytokeratin, 200.neuroendocrine granules detected by ultrastructural observa-
tions.1,7,8 Tumor of the present case was immunohistochemically
positive for these neuroendocrine antigens. Thus, the present tumor
is pulmonary neuroendocrine tumor. The histologies also indicate
that the tumor of the present case is a neuroendocrine tumor.
These pulmonary neuroendocrine tumors have different
morphologies and biological behaviors. Typical and atypical carci-
noids show ribbon-like, trabecular, sinusoidal, insular, and organoid
pattern.1 The tumor cells were monotonous and do not show
apparent malignant features.1 Typical carcinoid is potentially
malignant, whose malignant potential depends on tumor size and
cellular atypia. Atypical carcinoma is low grade malignant tumor,
and also called malignant carcinoid. The differentiation between
typical and atypical carcinoids depends on mitotic activity and
necrosis.1,7–9 The histology of LCNEC is that of large cell carcinoma.
Of large cell carcinoma, the tumors with neuroendocrine features
are called LCNEC. LCNEC is an aggressive tumor. SCLC is cytologically
characterized by small cells with hyperchromatic nuclei, negative
nucleoli, nuclear molding, numerous mitoses, and scant cytoplasm.
SCLC does not show carcinoid-like histological features such as
ribbon and trabecular features. SCLC is highly aggressive tumor.
Therefore, the tumor of the present case is an atypical carcinoid.
The origin of these neuroendocrine tumors is considered to be
endocrine cells present in the bronchus or Kulchitsky cells or APUD
cells.10–12 These cells are often seen in fetal bronchi and are
believed to be of endodermal origin.10,11 In the present case, the
only involved organ is bronchus. The observations suggest that
endocrine cells normally present in the bronchial epithelium
undergo tumor formation, thus leading to the atypical carcinoid
within the bronchial lumens.
Very interestingly, the tumor of the present case showed mac-
roscopical features of bronchial tree-like casts. Carcinoid tumor of
the lung occasionally show intrabronchial polyp.1–4 However, the
bronchial tree-like cast as seen in the present study is very rare, and
the author cannot ﬁnd such a case in the English literature.
Microscopical examination also indicated that the tumor of the
present case were totally located in the bronchial lumen, without
lung parenchymal invasion or involvement. The intrabronchial
growth reﬂects that the intrabronchial space is free of resistance for
cancer invasion. The negative parenchymal invasion in the present
case suggests that the invasive biological behavior is lacking or very
little in the present study. The absence of lymphovascular perme-
ation of the present case shows no aggressive biological behavior.
These benign biological behaviors may be associated with presence
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and lack of many molecules involved in tumor cell invasion,
including matrix metalloproteinases.15
The prognosis of atypical carcinoid is relatively poor. The 5- and
10-year survival was 56 and 35%, respectively.7 Other studies
showed 69 and 59%, respectively,8 and still others 77 and 53%,
respectively.9 In the present case, the surgical margin was negative
and the tumor did not involve the pleura. In addition, there was no
lymphovascular permeation. The author thought that the tumor
was totally resected, and anticipated that the prognosis is relatively
good. In fact, the patient is now healthy without recurrence and
metastasis seven years after the operation.
In summary, clinicians and pathologists should be aware that
atypical carcinoid can show bronchial tree-like casts within bron-
chial lumens without parenchyma invasion. Such atypical carci-
noids may have favorable prognosis.
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